financetom
Business
financetom
/
Business
/
Erasca Q2 Loss Narrows, Cash Runway Good Until H2 2028
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Erasca Q2 Loss Narrows, Cash Runway Good Until H2 2028
Aug 12, 2025 2:24 PM

05:08 PM EDT, 08/12/2025 (MT Newswires) -- Erasca ( ERAS ) reported a Q2 loss of late Tuesday of $0.12 per diluted share, narrowing from a loss of $0.29 a year earlier.

Two analysts polled by FactSet expected $0.12.

As of June 30, the company had cash, cash equivalents, and securities of $386.7 million, expected to fund operations into H2 2028.

Shares were down 4.5% during after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rambus Insider Sold Shares Worth $920,973, According to a Recent SEC Filing
Rambus Insider Sold Shares Worth $920,973, According to a Recent SEC Filing
Oct 6, 2025
04:14 PM EDT, 10/06/2025 (MT Newswires) -- Desmond Lynch, Senior Vice President, CFO, on October 06, 2025, sold 9,074 shares in Rambus ( RMBS ) for $920,973. Following the Form 4 filing with the SEC, Lynch has control over a total of 55,356 common shares of the company, with 55,356 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/917273/000119312525231877/xslF345X05/ownership.xml ...
Dynatrace Insider Sold Shares Worth $3,000,849, According to a Recent SEC Filing
Dynatrace Insider Sold Shares Worth $3,000,849, According to a Recent SEC Filing
Oct 6, 2025
04:11 PM EDT, 10/06/2025 (MT Newswires) -- Rick M McConnell, Director, Chief Executive Officer, on October 02, 2025, sold 60,000 shares in Dynatrace ( DT ) for $3,000,849. Following the Form 4 filing with the SEC, McConnell has control over a total of 138,625 common shares of the company, with 138,125 shares held directly and 500 controlled indirectly. SEC Filing:...
MapLight Therapeutics Announces Commencement of Initial Public Offering
MapLight Therapeutics Announces Commencement of Initial Public Offering
Oct 6, 2025
SAN FRANCISCO and BOSTON, Oct. 6, 2025 /PRNewswire/ -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the SEC) in connection with the commencement of a proposed initial...
EV maker Lucid's quarterly deliveries rise but fall short of expectations
EV maker Lucid's quarterly deliveries rise but fall short of expectations
Oct 6, 2025
(Reuters) -Lucid reported a 46.6% jump in third-quarter deliveries on Monday, driven by a rush of demand for electric vehicles before lucrative tax credits expired last week, but it still missed Wall Street expectations. The EV maker and its rivals are bracing for a sharp drop in sales in the last three months of the year without the $7,500 in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved